Gábor Kapus

Title: Gábor Kapus: Innovator in GABAA A5 Receptor Modulation

Introduction

Gábor Kapus is a notable inventor based in Pécel, Hungary. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the GABAA A5 receptor. His work is essential for advancing treatments for various neurological conditions.

Latest Patents

Gábor Kapus holds a patent for "Bicyclic derivatives as GABAA A5 receptor modulators." This invention provides compounds that exhibit affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5. These compounds act as GABAα5 negative allosteric modulators, making them useful in the treatment or prevention of diseases related to the GABAα5 receptor. The patent also covers the processes for preparing these compounds, pharmaceutical compositions that include them, and their use as medicaments.

Career Highlights

Gábor Kapus is associated with Richter Gedeon Nyrt., a prominent pharmaceutical company in Hungary. His work at the company has allowed him to focus on innovative solutions in drug development, particularly in the area of neurological disorders.

Collaborations

Throughout his career, Gábor has collaborated with esteemed colleagues such as György Szabó and György István Túrós. These collaborations have contributed to the advancement of research and development in their field.

Conclusion

Gábor Kapus is a distinguished inventor whose work on GABAA A5 receptor modulators has the potential to impact the treatment of neurological diseases significantly. His contributions to pharmacology and collaboration with other experts highlight his commitment to innovation in medicine.